Entry Detail



General Information

Database ID:exR0226391
RNA Name:hsa-miR-16-5p
RNA Type:miRNA
Chromosome:chr3
Starnd:+
Coordinate:
Start Site(bp):160404754End Site(bp):160404775
External Links:hsa-miR-16-5p



Disease Information

Disease Name:Active Tuberculosis
Disease Category:Infections
MeSH ID:D014376
Type:Diseases Category/Infections
Alias:Tuberculosis//Tuberculoses//Kochs Disease//Koch's Disease//Koch Disease//Mycobacterium tuberculosis Infection//Infection, Mycobacterium tuberculosis//Infections, Mycobacterium tuberculosis//Mycobacterium tuberculosis Infections



Expression Detail

GEO ID:GSE124120
Description:Small RNA Profiles of Serum Exosomes Derived from Individuals with Latent and Active Tuberculosis
Experimental Design:Disease vs Control
Case Disease Type:Active Tuberculosis
Case Disease SubType:NA
Case Sample:Active Tuberculosis
Control Sample:Healthy
Number of Case:1
Number of Control:1
Number of Samples:2





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AMER1
chrX
64185117
64205708
-
ANKRD17
chr4
73073376
73258798
-
ARHGAP35
chr19
46860997
47005077
+
ARHGDIA
chr17
81867721
81871378
-
ARRDC4
chr15
97960703
97973833
+
ASB1
chr2
238426742
238452250
+
ATXN7L3
chr17
44191805
44200113
-
BACE1
chr11
117285207
117316259
-
BIRC5
chr17
78214186
78225636
+
CYB561A3
chr11
61348745
61362299
-
DCAF7
chr17
63550477
63594279
+
FAM89A
chr1
231018958
231040254
-
FLOT2
chr17
28879335
28897733
-
FSD1
chr19
4304598
4323843
+
ITPR1
chr3
4493345
4847840
+
JARID2
chr6
15246069
15522042
+
KDSR
chr18
63327726
63367228
-
MAPK1IP1L
chr14
55051647
55070194
+
MAPKBP1
chr15
41774434
41827855
+
PLPP6
chr9
4662294
4665258
+
RTL8B
chrX
135020513
135022542
-
SEC61A1
chr3
128051641
128071683
+
STEAP3
chr2
119223831
119265652
+
TBRG1
chr11
124622836
124635926
+
TOB2
chr22
41433494
41446801
-
UNC119B
chr12
120710458
120723640
+
ZBTB34
chr9
126860665
126885878
+
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000540
chr14
55799534
55821940
+
hsa_circ_0001005
chr2
53921020
53978078
-
hsa_circ_0001723
chr7
91924202
91948826
+
hsa_circ_0000458
chr12
124071293
124074996
+
hsa_circ_0001699
chr7
40027197
40041630
+
hsa_circ_0001387
chr4
1902352
1936989
+
hsa_circ_0001168
chr20
47691321
47707559
+
hsa_circ_0000552
chr14
71880664
71948928
+
hsa_circ_0000038
chr1
28800065
28802803
+
hsa_circ_0000652
chr15
90984737
90986710
+
hsa_circ_0001472
chr5
36953719
36976504
+
hsa_circ_0001263
chr3
5215701
5216099
+
hsa_circ_0000799
chr17
65941524
65972074
+
hsa_circ_0001164
chr20
45891031
45923523
-
hsa_circ_0000032
chr1
25666964
25669564
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC079781.5
chr7
97851688
97972985
-
HCG18
chr6
30286690
30327382
-
XIST
chrX
73820649
73852723
-
FGD5-AS1
chr3
14920347
14948424
-
LINC00649
chr21
33915534
33977691
+
AC009022.1
chr16
69976297
70065948
-
AC114980.1
chr5
93860669
93863825
-
AC002470.2
chr22
20979462
20998121
+
SNHG16
chr17
76557764
76565348
+
LINC01184
chr5
127939152
128083172
-
NEAT1
chr11
65422774
65445540
+
AC021078.1
chr5
149494314
149504670
-
AL359924.1
chr1
237862175
237928321
+
LINC02035
chr3
122886941
122892416
+
NUTM2B-AS1
chr10
79661394
79826594
-
SNHG25
chr17
64145970
64146476
+
AC003092.1
chr7
94022833
94066661
+
AP000317.2
chr21
34073592
34360033
+
MIR497HG
chr17
7015818
7019659
-
SNHG12
chr1
28578538
28583132
-
MIR29B2CHG
chr1
207801518
207879115
-
AC020978.7
chr16
68224713
68227734
+
MZF1-AS1
chr19
58559129
58574797
+
SNHG1
chr11
62851984
62855953
-
MCM3AP-AS1
chr21
46229196
46259390
+
LINC00662
chr19
27681072
27794005
-
NUTM2A-AS1
chr10
87201647
87342612
-
AL031282.2
chr1
1702736
1737688
-
MIR503HG
chrX
134543119
134546642
-
AL391244.1
chr1
1420245
1422691
+
Display:



Experiment Detail

GEO ID:GSE124120
Sample Source:Blood
Source Fraction:Exosome
Platform:GPL16791
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:356
Sample treatment protocol:We first performed differential centrifugation (1000 g for 10 min at 4 °C, and 16,500 g for 30 min at 4 °C) to remove the cell debris, followed by ultrafiltration using 0.22 um filters. We then performed ultracentrifugation (120,000 g for 2 hours) to obtain exosome pellets. Transmission electron microscopy (TEM) was employed to visualize exosomes. The exosome pellets were first suspended and dropped onto 200 mesh copper grids, followed by incubation in 3% phosphotungstic acid for 10 min. The copper mesh was then washed three times with water and dried for observation by TEM. We also analyzed the exosome size distributions using the nanoparticle tracking analysis (NTA, Malvern, UK) according to the manufacturer's instructions.
RNA Extract protocol:NA
RNA library preparation protocol:Small RNA libraries were prepared for sequencing using standard Illumina protocols.



Reference

PMID:https://doi.org/10.3389/fmicb.2019.01174
Title:Small RNA Profiles of Serum Exosomes Derived From Individuals With Latent and Active Tuberculosis
Author:Lingna Lyu, Xiuli Zhang, Cuidan Li, Tingting Yang, Jinghui Wang, Liping Pan, Hongyan Jia, Zihui Li, Qi Sun, Liya Yue, Fei Chen and Zongde Zhang
Journal:Front. Microbiol., 28 May 2019 | https://doi.org/10.3389/fmicb.2019.01174
Description:In this study, we performed small RNA sequencing to explore small RNA profiles of serum exosomes derived from LTBI and TB patients and healthy controls (HC).